3-[[4,4-difluoro-1-[(2-methylpropan-2-yl)oxycarbonyl]piperidin-3-yl]methoxy]-5-(5-methyl-1,3-thiazol-2-yl)benzoic acid

C22H26F2N2O5S — CID 121397647

IUPAC3-[[4,4-difluoro-1-[(2-methylpropan-2-yl)oxycarbonyl]piperidin-3-yl]methoxy]-5-(5-methyl-1,3-thiazol-2-yl)benzoic acid
SMILESCc1cnc(-c2cc(OCC3CN(C(=O)OC(C)(C)C)CCC3(F)F)cc(C(=O)O)c2)s1
InChIInChI=1S/C22H26F2N2O5S/c1-13-10-25-18(32-13)14-7-15(19(27)28)9-17(8-14)30-12-16-11-26(6-5-22(16,23)24)20(29)31-21(2,3)4/h7-10,16H,5-6,11-12H2,1-4H3,(H,27,28)
InChIKeyVMUNJLPRMMYZJW-UHFFFAOYSA-N
MW468.52 g/mol
LogP5.09
Rot. Bonds5

About 3-[[4,4-difluoro-1-[(2-methylpropan-2-yl)oxycarbonyl]piperidin-3-yl]methoxy]-5-(5-methyl-1,3-thiazol-2-yl)benzoic acid

3-[[4,4-difluoro-1-[(2-methylpropan-2-yl)oxycarbonyl]piperidin-3-yl]methoxy]-5-(5-methyl-1,3-thiazol-2-yl)benzoic acid (PubChem CID 121397647) has the molecular formula C22H26F2N2O5S and a molecular weight of 468.52 g/mol. Its IUPAC name is 3-[[4,4-difluoro-1-[(2-methylpropan-2-yl)oxycarbonyl]piperidin-3-yl]methoxy]-5-(5-methyl-1,3-thiazol-2-yl)benzoic acid.

Molecular Properties

Compound Name3-[[4,4-difluoro-1-[(2-methylpropan-2-yl)oxycarbonyl]piperidin-3-yl]methoxy]-5-(5-methyl-1,3-thiazol-2-yl)benzoic acid
PubChem CID121397647
Molecular FormulaC22H26F2N2O5S
Molecular Weight468.52 g/mol
Exact Mass468.15
IUPAC Name3-[[4,4-difluoro-1-[(2-methylpropan-2-yl)oxycarbonyl]piperidin-3-yl]methoxy]-5-(5-methyl-1,3-thiazol-2-yl)benzoic acid
SMILESCc1cnc(-c2cc(OCC3CN(C(=O)OC(C)(C)C)CCC3(F)F)cc(C(=O)O)c2)s1
InChIInChI=1S/C22H26F2N2O5S/c1-13-10-25-18(32-13)14-7-15(19(27)28)9-17(8-14)30-12-16-11-26(6-5-22(16,23)24)20(29)31-21(2,3)4/h7-10,16H,5-6,11-12H2,1-4H3,(H,27,28)
InChIKeyVMUNJLPRMMYZJW-UHFFFAOYSA-N
XLogP5.09
TPSA88.96 Ų
H-Bond Donors1
H-Bond Acceptors6
Rotatable Bonds5
Heavy Atoms32
Complexity

Lipinski Rule of Five

1 violation

RuleValue
MW ≤ 500468.52
LogP ≤ 55.09
H-Bond Donors ≤ 51
H-Bond Acceptors ≤ 106

Analyze 3-[[4,4-difluoro-1-[(2-methylpropan-2-yl)oxycarbonyl]piperidin-3-yl]methoxy]-5-(5-methyl-1,3-thiazol-2-yl)benzoic acid with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of 3-[[4,4-difluoro-1-[(2-methylpropan-2-yl)oxycarbonyl]piperidin-3-yl]methoxy]-5-(5-methyl-1,3-thiazol-2-yl)benzoic acid?
The IUPAC name of 3-[[4,4-difluoro-1-[(2-methylpropan-2-yl)oxycarbonyl]piperidin-3-yl]methoxy]-5-(5-methyl-1,3-thiazol-2-yl)benzoic acid (CID 121397647) is 3-[[4,4-difluoro-1-[(2-methylpropan-2-yl)oxycarbonyl]piperidin-3-yl]methoxy]-5-(5-methyl-1,3-thiazol-2-yl)benzoic acid.
What is the SMILES notation for 3-[[4,4-difluoro-1-[(2-methylpropan-2-yl)oxycarbonyl]piperidin-3-yl]methoxy]-5-(5-methyl-1,3-thiazol-2-yl)benzoic acid?
The canonical SMILES for 3-[[4,4-difluoro-1-[(2-methylpropan-2-yl)oxycarbonyl]piperidin-3-yl]methoxy]-5-(5-methyl-1,3-thiazol-2-yl)benzoic acid is Cc1cnc(-c2cc(OCC3CN(C(=O)OC(C)(C)C)CCC3(F)F)cc(C(=O)O)c2)s1.
What is the InChIKey of 3-[[4,4-difluoro-1-[(2-methylpropan-2-yl)oxycarbonyl]piperidin-3-yl]methoxy]-5-(5-methyl-1,3-thiazol-2-yl)benzoic acid?
The InChIKey is VMUNJLPRMMYZJW-UHFFFAOYSA-N. The full InChI is InChI=1S/C22H26F2N2O5S/c1-13-10-25-18(32-13)14-7-15(19(27)28)9-17(8-14)30-12-16-11-26(6-5-22(16,23)24)20(29)31-21(2,3)4/h7-10,16H,5-6,11-12H2,1-4H3,(H,27,28).
What are the key properties of 3-[[4,4-difluoro-1-[(2-methylpropan-2-yl)oxycarbonyl]piperidin-3-yl]methoxy]-5-(5-methyl-1,3-thiazol-2-yl)benzoic acid?
3-[[4,4-difluoro-1-[(2-methylpropan-2-yl)oxycarbonyl]piperidin-3-yl]methoxy]-5-(5-methyl-1,3-thiazol-2-yl)benzoic acid has a molecular weight of 468.52 g/mol, XLogP of 5.09, 5 rotatable bonds, 1 hydrogen bond donors, and 6 hydrogen bond acceptors.
Where does this data come from?
All data for 3-[[4,4-difluoro-1-[(2-methylpropan-2-yl)oxycarbonyl]piperidin-3-yl]methoxy]-5-(5-methyl-1,3-thiazol-2-yl)benzoic acid is sourced from PubChem (CID 121397647), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).